Original Article

Clinical and genetic features of seven patients with neurodegeneration with brain iron accumulation

  • ZHAO Peiwei ,
  • ZHANG Lei ,
  • MENG Qingjie ,
  • HE Xuelian
Expand
  • 1. Precision Medical Center, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, Hubei, China
    2. Clinical Laboratory, Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430016, Hubei, China

Received date: 2024-04-19

  Accepted date: 2024-08-30

  Online published: 2025-02-27

Abstract

Objective The aim of this study was to explore the clinical and genetic characteristics of 7 pediatric patients with neurodegeneration with brain iron accumulation (NBIA). Methods Genetic mutation analysis was conducted on patients suspected of having NBIA using whole exome sequencing (WES), followed by Sanger sequencing for positive cases. A retrospective analysis of the patients' clinical data was performed alongside a literature review. Results Seven patients, comprising five boys and two girls with an average age of 5.4±3.8 years, presented to the hospital primarily due to motor developmental delay. The main clinical manifestations included intellectual disability, gait disorders, abnormal posture, delayed or regressed psychomotor development, muscle weakness, cerebellar ataxia, and retinitis pigmentosa. WES identified pathogenic mutations in NBIA-related genes in all 7 patients, specifically PANK2 in one case, FA2H in one case, and PLA2G6 in five cases. Patients with PLA2G6 variations exhibited early onset, developmental delay, muscle weakness, low signal iron deposition in the pallidus, and cerebellar atrophy. The patient with a PANK2 gene mutation showed gait and postural abnormalities, while the patient with an FA2H mutation presented with language delay, gait abnormalities, and dysmyotonia. Conclusion There is significant heterogeneity in the clinical phenotype of NBIA patients, with neurological abnormalities being the predominant feature. Two previously unreported variants were identified, broadening the spectrum of genetic variations in NBIA disease.

Cite this article

ZHAO Peiwei , ZHANG Lei , MENG Qingjie , HE Xuelian . Clinical and genetic features of seven patients with neurodegeneration with brain iron accumulation[J]. Journal of Clinical Pediatrics, 2025 , 43(3) : 199 -203 . DOI: 10.12372/jcp.2025.24e0318

References

[1] Hayflick SJ, Kurian MA, Hogarth P. Neurodegeneration with brain iron accumulation[J]. Handb Clin Neurol, 2018, 147: 293-305.
[2] Hajati R, Emamikhah M, Danaee Fard F, et al. Neuro-degeneration with brain iron accumulation and a brief report of the disease in Iran[J]. Can J Neurol Sci, 2022, 49(3): 338-351.
[3] 中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会. 脑组织铁沉积神经变性病诊治专家共识[J]. 中华医学杂志, 2016, 96(27): 2126-2133.
  Parkinson's Disease and Movement Disorders Group of the Neurology of the Chinese Medical Association, Parkinson's Disease and Movement Disorders Professional Committee of the Neurology of the Chinese Medical Association. Expert consensus on the diagnosis and treatment of neurodegenerative diseases caused by iron deposition in brain tissue[J]. Zhonghua Yixue Zazhi, 2016, 96(27): 2126-2133.
[4] McNeill A, Birchall D, Hayflick SJ, et al. T2 and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation[J]. Neurology, 2008, 70(18): 1614-1619.
[5] 吕占云, 郭纪锋, 李凯, 等. 脑组织铁沉积性神经变性疾病研究进展[J]. 中华神经科杂志, 2015, 48 (2): 152-156.
  Lyu ZY, Guo JF, Li K, et al. Progress on neurodegenerative diseases caused by iron deposition in brain tissue[J]. Zhonghua Shenjingke Zazhi, 2015, 48(2):152-156.
[6] Lehéricy S, Roze E, Goizet C, et al. MRI of neuro-degeneration with brain iron accumulation[J]. Curr Opin Neurol, 2020, 33(4): 462-473.
[7] Li WB, Shen NX, Zhang C, et al. Novel PANK2 mutations in patients with pantothenate kinase-associated neurodegeneration and the genotype-phenotype correlation[J]. Front Aging Neurosci, 2022, 14: 848919.
[8] Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424.
[9] Pan S, Zhu C. Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature[J]. Neurocase, 2020, 26(3):175-182.
[10] Villessot M, Demailly D, Chan-Seng E, et al. Unpredicted failure of deep brain stimulation by the impedance measures in a child with severe PANK2-gene related generalized dystonia[J]. Brain Stimul, 2022, 15(4): 921-923.
[11] Hanna Al-Shaikh R, Milanowski LM, Holla VV, et al. PLA2G6-associated neurodegeneration in four different populations-case series and literature review[J]. Parkinsonism Relat Disord, 2022, 101: 66-74.
[12] Deng X, Yuan L, Jankovic J, et al. The role of the PLA2G6 gene in neurodegenerative diseases[J]. Ageing Res Rev, 2023, 89: 101957.
[13] Iodice A, Spagnoli C, Salerno GG, et al. Infantile neuroaxonal dystrophy and PLA2G6-associated neuro-degeneration: An update for the diagnosis[J]. Brain Dev, 2017, 39(2): 93-100.
[14] 谢曼青, 袁晶, 郝红琳, 等. PLA2G6相关帕金森综合征6例临床与遗传学特点并文献复习[J]. 中华神经科杂志, 2023, 56(12): 1389-1397.
  Xie MQ, Yuan J, Hao HL, et al. Clinical and genetic characteristics of 6 cases of PLA2G6 related Parkinson's syndrome and literature review[J]. Zhonghua Shenjingke Zazhi, 2015, 48(2):152-156.
[15] Eckhardt M. Fatty acid 2-hydroxylase and 2-hydroxylated sphingolipids: metabolism and function in health and diseases[J]. Int J Mol Sci, 2023, 24(5): 4908.
[16] Bekta? G, Ye?il G, Y?ld?z EP, et al. Hereditary spastic paraplegia type 35 caused by a novel FA2H mutation[J]. Turk J Pediatr, 2017, 59(3): 329-334.
[17] Hashemi N, Abadi RNS, Alavi A, et al. The first reports of FA2H-associated neurodegeneration from two unrelated Iranian families[J]. Neurol Sci, 2023, 44(12): 4359-4362.
[18] Meyer E, Kurian MA, Hayflick SJ. Neurodegeneration with brain iron accumulation: genetic diversity and pathophysiological mechanisms[J]. Annu Rev Genomics Hum Genet, 2015, 16:257-279.
Outlines

/